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Acute Otitis Externa is an inflammation of the outer 
auditory meatus, and according to popular saying, 
medicinal plant extracts can be used in its treatment. Aim: 
to assess the in vitro antimicrobial activity of the following 
plants: Aleolanthus suaveolens; Caryophyllus aromaticus; 
Cymbopogon citratus; Matricaria chamomila; Pithecellobium 
avaremotemo; Plectranthus amboinicus and Ruta graveolens 
on the germs that cause otitis externa. Materials and 
Methods: the minimum inhibitory concentration of extracts 
and oils from these plants was obtained from otitis externa 
samples. Results: Staphylococcus aureus in 10 cultures, 
Pseudomonas aeruginosa in 8, Pseudomonas aeruginosa and 
Staphylococcus aureus together in 5 cultures and Candida 
albicans and Candida krusei in 4 cultures. P. aeruginosa 
was resistant to all oils and extracts tested; extracts from A. 
suaveolens, P. avaremotemo and R. graveolens were inactive; 
the essential oil from C. aromaticus and M. chamomila 
were active against 3 strains of S. aureus and the Candida 
strains; seven of the S. aureus strains were sensitive to the 
P. amboinicus extract; however, the oil was inactive against 
4 S. aureus strains and the Candida strains were sensitive 
to the R. graveolens essential oil. Conclusion: depending 
on the etiological agent, some plants presented satisfactory 
results, however we still need more detailed studies in order 
to better use these plants. 
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INTRODUCTION
Otitis externa is basically an inflammation on the 
external acoustic meatus skin, frequently associated with 
a secondary bacterial infection and/or fungal infection on 
the macerated skin of the subcutaneous tissue.1,2 It can be 
classified into diffuse, which is a dermatitis, when there is 
a reduction in wax production, epithelial scaling and ede-
ma; or localized, in this case it is a furuncle, caused by an 
infection in the pilosebaceous foliculum.1,2 In folk’s medici-
ne, it is common to use medicinal Brazilian plants such as 
arruda, macassá, barbatimão, among others, depending on 
the region, without however, any scientific study justifying 
its use. The World Health Organization advocates the use 
of medicinal plants, especially in public health care pro-
grams in developing countries.3,4 The plants can be used 
as infusion, macerated, as juice, tinctures, infiltrates  or 
patches, for the treatment of diseases.3,5 They have many 
secondary metabolic pathways which will create compoun-
ds that include alkaloids, flavonoids, isoflavonoids, tannins, 
coumarins, glycosides, terpenes, polyacetylenes, which 
are specific to certain families, genera or species and that 
have many functions.5 Otitis externa is preferably treated 
topically, considering antimicrobial resistance stemming 
today as a risk to its therapeutic efficacy. Considering the 
prevalence and morbidity of this disease and the very 
possibility of having other means of treatment, this study 
aimed at assessing the in vitro antimicrobial activity of 
these plants’ extracts and essential oils on microorganisms 
taken from patients with acute otitis externa. 
MATERIALS AND METHODS
Twenty-seven patients with clinical diagnosis of 
AOE (Acute Otitis Externa) without ear drum perforation 
nor prior use of medication,6 were selected, regardless 
of gender and age, during a period of three months, and 
we collected material from the involved ear, by using a 
Swab, following the standards and guidelines established 
for research projects involving human beings - Resolution 
# 196/1996 - Brazilian Ministry of Health.7 The study was 
approved by the ethics committee of the Lauro Wander-
lei University Hospital, protocol #  341, and the patients 
signed an informed consent form in order to take part 
in the project. In order to check for antibacterial activity 
on the plants’ extracts and essential oils, we isolated and 
identified the bacterial species, according to microbiolo-
gy routines,8-10 and the samples were kept in agar Miller 
Hinton (Difco Laboratories Ltd.). From otomycosis we 
isolated and identified yeasts by macro and micro mor-
phological and biochemical characteristics.11-15 The strains 
were kept in 2% agar Saboraud dextrose (ASD)  (Difco 
Laboratories Ltda), stored at room temperature and at 4ºC. 
The extracts and essential oils used in the antimicrobial 
activity assays were obtained from the four plant species 
included on Chart 1. In order to assess antimicrobial acti-
vity, we tested the extracts in the following concentrations: 
5000, 2500, 1250, 625, 313, 156 and 78µg/ml, solubilized 
in dimethyl-sulphoxyde-DSO, at a maximum rate of 10% 
and the essential oils were tested in the concentrations 
of 8, 4, 2, 1, 0.5 and 0.25%, according to Allegrini et al’s 
technique. 1973.16,17
We carried out antibacterial and antifungal activities 
assays to determine the minimum inhibitory concentration 
MIC of extracts and essential oils by the diffusion in solid 
medium method - cavity-plate process.9,16 Control was 
carried out by antibiogram.
Chart 1. Plant species and respective products used to assess their antimicrobial activity on bacteria and fungi.
Gender/ Species Family Common name Obtainment Plant part Product tested
Aleolanthus suaveolens Spreng. 
Labiatae
Macassá
Obtained from a natural pro-
ducts’ store
Leaf Extract
Caryophyllus aromaticus L. Myrta-
ceae
Cravo-da-índia
Obtained from a natural pro-
ducts’ store
Leaf Base oil
Cymbopogon citratus Stapf. Gra-
mineae
Capim-santo Medicinal plants garden - UFPB Leaves Base oil
Matricaria chamomila (L) Rausch 
Asteraceae
Camomila
Obtained from a natural pro-
ducts’ store
Leaves and flowers Base oil
Pithecellobium avaremotemo Mart. 
Fabaceae (Leguminosae)
Barbatimão
Obtained from a natural pro-
ducts’ store
Stem’s skin Extract
Plectranthus amboinicus Lour La-
miaceae
Hortelã da folha grossa Medicinal plants garden - UFPB Leaves Base oil/extract
Ruta graveolens L. Rutaceae Arruda Medicinal plants garden - UFPB Leaves Base oil/extract
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RESULTS
We observed Staphylococcus aureus in 10 cultures 
(37%), Pseudomonas aeruginosa in 8 cultures (29.6%), 
Pseudomonas aeruginosa and Staphylococcus aureus 
together in 5 cultures (18.5%), and Candida in 4 cultures, 
(14.9%), in all cases, they were associated with Gram 
Positive and Gram Negative Bacteria.
In the present investigation we assessed the in vi-
tro antibacterial and antifungal activity of extracts and/or 
essential oils of the following medicinal plants: macassá, 
barbatimão, cravo-da-índia, capim-santo, camomila, hor-
telã da folha grossa and arruda against twelve strains of 
P. aeruginosa, eight strains of S. aureus, one strain of C. 
albicans and one strain of C. krusei.
One can see that all fungal and bacterial species 
investigated resisted the extract of A. suaveolens, Pithe-
cellobium avaremotemo and Ruta graveolens.
On Table 1 we list the results of antibacterial activity 
for the essential oil from C. aromaticus. Pseudomonas 
genera was completely resistant to this essential oil in all 
concentrations. In the same concentration of 4% it was 
active against the growth of three strains of Staphylococcus 
and two strains of Candida.  We can see that C. albicans 
and C. Krusei were sensitive in concentrations of up to 
1%, with 10 mm in diameter inhibition halos.
The essential oil from M. chamomila did not pro-
duce inhibition on Pseudomonas; however, in the concen-
tration of 4%, it had an inhibitory activity on the growth 
of three strains of Staphylococcus and two Candida strains 
with inhibition halos varying between 10 and 12mm in 
diameter (Table 2).
Table 1. Average value of inhibition halos (mm) of MIC assessment of C. aromaticus essential oil against bacteria and fungus in solid medium. 
Microorganisms
Essential oil from C. aromaticus (%) Control
8 4 2 1 0,5 0,25 Microorganisms
S. aureus (1) 13 10 8 0 0 0 +
S. aureus (2) 0 0 0 0 0 0 +
S. aureus (3) 12 3 0 0 0 0 +
S. aureus (4) 11 0 0 0 0 0 +
S. aureus (5) 0 0 0 0 0 0 +
S. aureus (6) 10 8 0 0 0 0 +
S. aureus (7) 13 10 0 0 0 0 +
S. aureus (8) 12 10 0 0 0 0 +
C. albicans (1) 20 16 14 10 0 0 +
C. krusei (2) 22 18 15 10 0 0 +
+: Microorganism control in the culture medium without antimicrobial agent. 
Table 2. Mean values of MIC assessment inhibition halos (mm) from the essential oil of M. chamomila against bacteria and fungi, in solid me-
dium.
Microorganisms
Essential oil from M. camomila (%) Control
8 4 2 1 0,5 0,25 Microorganisms
S. aureus (1) 0 0 0 0 0 0 +
S. aureus (2) 14 10 0 0 0 0 +
S. aureus (3) 0 0 0 0 0 0 +
S. aureus (4) 10 8 0 0 0 0 +
S. aureus (5) 0 0 0 0 0 0 +
S. aureus (6) 0 0 0 0 0 0 +
S. aureus (7) 15 10 0 0 0 0 +
S. aureus (8) 14 10 0 0 0 0 +
C. albicans (1) 14 10 0 0 0 0 +
C. krusei (2) 14 12 10 0 0 0 +
+: Microorganism control in a culture medium without antimicrobial agents.
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P. amboinicus extract in the present study proved 
to be active against seven of the eight copies of Staphylo-
coccus, with inhibition halos average of 13mm in diameter; 
however, it was not active against P. aeruginosa and Can-
dida ssp. (Table 3). The oil from this plant was not very 
effective in this study, showing action against two strains 
of  S. aureus and C. krusei strain in the concentrations of 8 
and 4% for the bacterium and 8, 4 and 2% for the fungus, 
these data are shown on Table 4.
The essential oil from Ruta graveolens extracts was 
assessed as to its antimicrobial action, because this plant 
has its popular use recognized in external ear pathology. 
The essential oil from R. graveolens at 4%, inhibited four 
Staphylococcus strains and all the Candida strains, with 
inhibition halos between 10 and 13 mm in diameter. These 
findings can be seen on Table 5; however, its extract did 
not show any activity.
Table 3. Inhibition halos (mm) mean value from the MIC assessment of P. amboinicus extract against bacteria and fungi in solid medium
Microorganisms
P. amboinicus  extract (µg/ml) Control
5000 2500 1250 625 313 156 78 Microorganism
S. aureus (1) 0 0 0 0 0 0 0 +
S. aureus (2) 17 13 0 0 0 0 0 +
S. aureus (3) 20 15 12 0 0 0 0 +
S. aureus (4) 17 13 7 0 0 0 0 +
S. aureus (5) 15 12 8 0 0 0 0 +
S. aureus (6) 15 12 0 0 0 0 0 +
S. aureus (7) 18 14 12 0 0 0 0 +
S. aureus (8) 18 14 12 0 0 0 0 +
C. albicans (1) 0 0 0 0 0 0 0 +
C. krusei (2) 0 0 0 0 0 0 0 +
+: Microorganism control in a culture medium without bacteria.
Table 4. Mean value of inhibition halos (mm) from the MIC assessment of the P. amboinicus essential oil against fungi and bacteria in solid 
medium.
Microorganism
 P. amboinicus essential oil (%) Control
8 4 2 1 0.5 0.25 Microorganism
S. aureus (1) 0 0 0 0 0 0 +
S. aureus (2) 0 0 0 0 0 0 +
S. aureus (3) 12 10 7 0 0 0 +
S. aureus (4) 10 0 0 0 0 0 +
S. aureus (5) 0 0 0 0 0 0 +
S. aureus (6) 12 10 0 0 0 0 +
S. aureus (7) 0 0 0 0 0 0 +
S. aureus (8) 0 0 0 0 0 0 +
C. albicans (1) 0 0 0 0 0 0 +
C. krusei (2) 14 12 10 0 0 0 +
+: Microorganism control in a culture medium without bacteria
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DISCUSSION
Otitis externa is an infectious inflammatory process, 
which affects the external auditory meatus skin and usually 
has polymicrobial etiology.2 Hwang, Chu and Liu (2002)18 
carried out a bacteriologic study in 161 patients and obser-
ved that S. aureus was as frequently found as P. aeruginosa 
in patients with otitis externa. These data ratify the findings 
of the present investigation, since there was no statistically 
significant difference between these bacteria. Kuczkowski 
et al. (2000)19, studied 55 cultures of patients with otitis 
externa and found a greater frequency of Staphylococcus 
aureus, Pseudomonas aeruginosa and Proteus mirabilis, 
similar to our findings; thus, we can  consider that the 
main etiology associated with otitis externa is bacterial, 
and occasionally fungal.18 As far as fungi are concerned, 
the genus Candida was found in 4 cultures, associated 
with Gram-positive and Gram negative bacteria. Similar 
findings were reported by Ologe et al. (2002)20, when they 
investigated 141 patients with presumed otomycosis, they 
confirmed the disease in 76 (53.9%), and the fungi most 
frequently found were Aspergillum sp (63.4%), Candida 
(35.5%) and Mucor (1.3%).
Despite high technology and heavy investments 
from the pharmaceutical industry in the production of 
increasingly more potent antimicrobial drugs, microbial 
resistance is on the rise.21 The use of plant components 
with therapeutic ends has increased in Brazil. According 
to the World Health Organization, the use of plant compo-
nents for therapeutic means has been on the rise in Brazil, 
and they also state that this can represent the best source 
of a variety of drugs.21,22 Nonetheless; these plants should 
not be used empirically, but rather based on controlled 
studies of efficacy and toxicity.
A. suaveolens - our macassá, although very much 
used in popular medicine for ear disorders, is not reported 
in the literature, both as antimicrobial drug as in terms 
of its analgesic and anti-inflammatory action that could 
justify its use, and in this study it was not efficient against 
the strains tested. 
P. avaremotemo extract, although active against 
bacteria and fungi in many studies, did not prove to have 
any activity against external ear microorganisms.23 These 
findings may be associated with pathogen virulence and/or 
extract characteristics.
The activity of essential oils and plant extracts 
against bacteria and fungi is due to the presence of phyto 
components, which concentration may vary depending 
on a number of factors, such as plant growing, harves-
ting and also the means used to obtain the extract or the 
essential oil.23,24
It has been reported that essential oils are more 
effective against Gram positive bacteria than Gram negati-
ve, but there still is no scientific explanation for this fact.21 
In the present study, the Gram negative P. aeruginosa 
bacteria resisted all tested oils, while the Gram positive 
S. aureus was sensitive to them, depending on the plant 
tested and its concentration.
The essential oil from C. aromaticus had an antimi-
crobial action against Gram positive bacteria, both in the 
literature studied as well as in the present investigation.23,24 
We observed that the essential oil from C. citratus was 
not active against the bacteria and fungi used in this stu-
dy; however, Araújo (2003)25 observed that this oil in the 
concentration of 8% was active against this fungi, but not 
against bacteria, as we found in this study.
The essential oil from M. chamomila inhibited the 
growth of Staphylococcus aureus and Bacillus subtilis 
Table 5. Inhibition halos mean value (mm) in MIC assessment of R. graveolens essential oil against bacteria and fungi, in solid medium.
Microorganism
R. graveolens essential oil (%) Control
8 4 2 1 0,5 0,25 Microorganism
S. aureus (1) 15 10 0 0 0 0 +
S. aureus (2) 10 0 0 0 0 0 +
S. aureus (3) 12 10 0 0 0 0 +
S. aureus (4) 15 10 0 0 0 0 +
S. aureus (5) 10 0 0 0 0 0 +
S. aureus (6) 16 12 10 8 0 0 +
S. aureus (7) 20 7 14 10 0 0 +
S. aureus (8) 10 8 0 0 0 0 +
C. albicans (1) 15 10 0 0 0 0 +
C. krusei (2) 17 13 10 0 0 0 +
+: Microorganism control in the culture medium without antimicrobial drug.
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and its hydro-alcoholic extract inhibited the growth of 
Staphylococcus aureus, Streptococcus mutans, Group 
B Streptococcus, Streptococcus salivarius, according to 
Jakovlev, 198326. In numerous papers, A M. chamomila 
presented antimicrobial activity, especially against P. 
aeruginosa27strains.
Catillo and Gonzälez (1999) observed that both the 
extract and the essential oil from P. amboinicus, harvested 
in Cuba, were active against Gram negative and Gram 
positive bacteria, as well as against yeasts and dermato-
phagoides, and the extract was more effective.28
According to Araújo (2003)25, the essential oil from 
R. graveolens was active against species of yeast, but not 
against S. aureus, similarly to the findings from Ross et 
al. (1980)29. However, Sá et al. (1995) noticed its activity 
against P. aeruginosa, S. aureus, B.subtilis25strains. These 
differences can be credited to the essential oil concentra-
tion and the microbial strains tested.
Further and more comprehensive studies with medi-
cinal plants in acute otitis externa are required, especially 
with those plants already advocated by popular medicine. 
However, it is worth stressing that this is the first appro-
ach carried out in the Northeast aiming at studying if any 
of these plants were effective against acute otitis externa 
causing agents, therefore we need further studies because 
this is a promising therapeutic alternative, especially for 
the needy population.
CONCLUSION
S. aureus, P. aeruginosa and fungi of the genera 
Candida were the most frequently found microorganisms 
in the culture of patients with acute otitis external. P. ae-
ruginosa was resistant to all tested extracts and essential 
oils. The essential oils from C. aromaticus and M. chamo-
mila at 4% inhibited the growth of three S. aureus strains 
and of all Candida strains; such activity was seen at the 
concentration of 1%. The essential oil from R. graveolens 
at 4% inhibited Candida strains and four S. aureus strains; 
and the extract from P. amboinicus had inhibitory activity 
against seven S. aureus strains, and Candida strains were 
resistant. Some plants have a satisfactory effect depending 
on the etiological agent. We still need more comprehensi-
ve and detailed studies regarding the use of these plants, 
because they can represent a promising therapeutic alter-
native in the near future, especially in regards of the more 
needy population. 
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